Praesidian Announces Successful Exit of its E-commerce Distribution Business

Praesidian Capital, a private equity firm headquartered in Oklahoma City, announced the successful exit of its tech-enabled e-commerce consumer products distribution business. Jason Drattell, Founder of Praesidian Capital, commented, “We are pleased to realize this investment and are appreciative of the opportunity to partner with a best-in-class management team. We are proud of what the […]

Immersive Surrealism with VNA: ROBERT WUN F/W 2025 Haute Couture

At the Paris Haute Couture Fashion Week, designer Robert Wun once again collaborates with the Professional Breast Patch Brand VNA to present an exciting and groundbreaking 2025 Fall/Winter collection showcase that defies fashion conventions. This marks the second collaboration between Wun and VNA. This season continues the brand's signature “dark dramatic” aesthetic, seamlessly merging both

NYSE:TGT Lawsuit Alert: Investors in shares of Target Corporation (NYSE:TGT) should contact the Shareholders Foundation

A lawsuit is pending for certain investors in Target Corporation (NYSE:TGT) shares. Investors who purchased Target Corporation (NYSE:TGT) shares prior to July 2022 and continue to hold any of those NYSE: TGT shares also have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. SAN DIEGO, CA /

Drone Contracts Soaring as Military Drone Market Size Projected to Reach $47 Billion By 2032

MarketNewsUpdates News Commentary The military drone market is poised to continue to grow over the coming years. A military drone, also known as an unmanned aerial vehicle (UAV), is a remotely piloted aircraft system used in military operations. These drones are equipped with advanced sensors and cameras that provide real-time situational awareness, aiding decision-making and

CITY FURNITURE MARKS SARASOTA GRAND OPENING AS CATALYST FOR TAMPA REGION GROWTH

CITY Furniture, Florida's leading home furnishings retailer, celebrated the successful grand opening of its new Sarasota showroom, marking an exciting milestone in the company's expansion across the Tampa Region. https://mma.prnewswire.com/media/2744702/City_Furniture_Sarasota_Showroom.jpg The 120,000-square-foot showroom opened with a ribbon-cutting on July 17, followed by a four-day celebration featuring $70,000 in giveaways, live DJs, food trucks, and exclusive

Baker Hill Selects LoanPro to Revolutionize Lending through a Seamless End-to-End Platform – From Origination to Servicing

Baker Hill, a leading provider of loan origination, risk management, and analytics software, today announced a strategic partnership with LoanPro, the market-leading modern loan management and servicing platform. Baker Hill chose LoanPro as its partner to delivera truly unified, modern lending experience, combining Baker Hill's robust loan origination capabilities with LoanPro's configurable servicing infrastructure for

Wearable Devices Announces Development of Neural Interface for Advanced Military Tactical Systems

(NASDAQ:WLDS),(NASDAQ:WLDSW), Yokneam Illit, Israel, Aug. 06, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced the launch of an innovative project to advance human-machine interfaces (“HMI”) for military applications. This cutting-edge initiative introduces a touchless

Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301

(NASDAQ:CINGW),(NASDAQ:CING), KANSAS CITY, Kan., Aug. 06, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release(TM) (PTR(TM)) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that it has submitted its New Drug Application (NDA) to the U.S. Food and Drug

Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced Pancreatic Cancer

(NasdaqGM:ACTU), Clinical Trial Study to be Conducted at UPMC Hillman Cancer to Evaluate Novel Combination as Frontline Therapy CHICAGO and FORT WORTH, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the

Wearable Devices Announces Development of Neural Interface for Advanced Military Tactical Systems

Wearable Devices Announces Development of Neural Interface for Advanced Military Tactical Systems GlobeNewswire August 06, 2025 Yokneam Illit, Israel, Aug. 06, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced the launch of an innovative

Scroll to Top